Jiangsu Lianhuan Pharmaceutical Co., Ltd. logo

Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513)

Market Closed
11 Aug, 06:57
SSE SSE
¥
17. 40
-0.27
-1.528%
¥
2.72B Market Cap
- P/E Ratio
0.6% Div Yield
23.19M Volume
- Eps
¥ 17.67
Previous Close
Add Transaction
Day Range
17.35 18.25
Year Range
13.67 32.27
Want to track 600513 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600513 closed today lower at ¥17.4, a decrease of -1.528% from yesterday's close, completing a monthly increase of 20.4986% or ¥2.96. Over the past 12 months, 600513 stock lost -4.814%.
600513 pays dividends to its shareholders, with the most recent payment made on Jul 08, 2026. The next estimated payment will be in In 10 months on Jul 08, 2027 for a total of ¥0.07.
The last earnings report, released on Mar 28, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0191%, based on the last three reports.
Jiangsu Lianhuan Pharmaceutical Co., Ltd. has completed 6 stock splits, with the recent split occurring on May 19, 2017.
The company's stock is traded on one exchange.

600513 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513) FAQ

What is the stock price today?

The current price is ¥17.40.

On which exchange is it traded?

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600513.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.6%.

What is its market cap?

As of today, the market cap is 2.72B.

Has Jiangsu Lianhuan Pharmaceutical Co., Ltd. ever had a stock split?

Jiangsu Lianhuan Pharmaceutical Co., Ltd. had 6 splits and the recent split was on May 19, 2017.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Ben Niu CEO
SSE Exchange
CNE000001DP6 ISIN
CN Country
1,296 Employees
8 Jul 2026 Last Dividend
19 May 2017 Last Split
4 Mar 2003 IPO Date

Overview

Jiangsu Lianhuan Pharmaceutical Co., Ltd. is a prominent pharmaceutical company that engages in the manufacture and sale of a broad spectrum of pharmaceutical products, including preparations and Active Pharmaceutical Ingredients (API). Founded in 1999 and headquartered in Yangzhou, China, the company has established a substantial international presence. It exports its diverse pharmaceutical products to various regions globally, including Southeast Asia, North America, South America, Europe, New Zealand, and Australia. Besides its core operations in pharmaceutical manufacturing, Jiangsu Lianhuan Pharmaceutical also participates in the wholesale of chemical raw materials and pharmaceuticals, sells medical equipment and electronic products, and offers services in medical technology research and development along with technological transfer.

Products and Services

  • Clopidogrel Bisulfate Tablets: These tablets are designed to prevent atherothrombotic events in patients, acting as a crucial preventive measure against heart conditions.
  • Doxycycline Hydrochloride Tablets: Targeted for treating a range of infections, these tablets are effective against upper respiratory tract infections, tonsilitis, biliary tract infections, lymphadenitis, cellulitis, and chronic bronchitis.
  • Azithromycin Tablets: These tablets are prescribed for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms, addressing a wide range of bacterial conditions.
  • Milrinone Injection: This is a short-term intravenous therapy used in patients with acute compensated heart failure, helping to improve heart function and patient condition temporarily.
  • Dapoxetine Hydrochloride Tablets: These tablets treat premature ejaculation, providing a solution for men suffering from this common sexual dysfunction.
  • Tadafil Tablets: Designed for men with erectile dysfunction, these tablets help in achieving and maintaining an erection.
  • Bepotastine Besilate Tablets: Used for allergy management, these tablets provide relief from itching eyes caused by allergic conjunctivitis.
  • Aiplete Tablets: Dedicated to treating benign prostatic hyperplasia, these tablets help in reducing the symptoms of enlarged prostate.
  • Ebastine Tablets: These tablets are utilized for the treatment of allergic rhinitis, providing relief from nasal allergic symptoms.
  • Felodipine Tablets: Prescribed for mild to moderate essential hypertension, these tablets aid in controlling high blood pressure.
  • Drotaverine Hydrochloride Injection: This injection is used to treat smooth muscle spasms caused by gastrointestinal diseases and to relieve dysmenorrhea, providing significant symptom relief.
  • Danazol Suppositories: Aimed at treating endometriosis, these suppositories help in reducing the pain and symptoms associated with the condition.
  • Terfenadine Tablets: These are used for treating allergic rhinitis and urticaria, providing relief from allergic symptoms.

In addition to these pharmaceutical products, Jiangsu Lianhuan Pharmaceutical Co., Ltd. offers a range of preparation products covering various therapeutic categories, including urinary system medications, antihistamines, cardiovascular drugs, steroid hormones, and antibiotics. Furthermore, the company engages in the wholesale of chemical raw materials and pharmaceuticals, sells medical equipment and electronic products, and provides services relating to medical technology research and development, along with technological transfer, showcasing a comprehensive portfolio of products and services designed to meet diverse healthcare needs.

Contact Information

Address: No. 9, Jiankang 1st Road, Yangzhou, China, 225127
Phone: 86 514 8277 8972